PDCD1 and melanoma: More examples include CRISPR-mediated gene knockout in intestinal tumors for functional validation of colorectal cancer driver genes [28] and a CRISPR-screen using a customized pool of sgRNAs in a melanoma cell line which is a novel gene involved in PD-1 resistance [29].